05/20/2013:
Elan's Response to Royalty Pharma Announcement More.
05/20/2013:
Elan Announces Transactions: Decisively Transforming the Company More.
05/20/2013:
Elan Announces Proposed Offering of US$800.0 Million in Aggregate Principal Amount of Senior Notes Due 2021 More.
